Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines - 19/04/17

Doi : 10.1016/j.jaci.2017.01.009

Lawrence F. Eichenfield, MD ^a,^b,^⁎ , Jusleen Ahluwalia, MD ^a,^b, Andrea Waldman, MD ^a,^b, Jenna Borok, BS ^a,^b, Jeremy Udkoff, MA ^a,^b, Mark Boguniewicz, MD ^c
^a Department of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, Calif
^b Department of Pediatric and Adolescent Dermatology, University of California, San Diego School of Medicine, La Jolla, Calif
^c Division of Pediatric Allergy-Immunology, Department of Pediatrics, National Jewish Health and University of Colorado School of Medicine, Denver, Colo

^∗Corresponding author: Lawrence F. Eichenfield, MD, 8010 Frost St, San Diego, CA 92123.8010 Frost StSan DiegoCA92123

Abstract

Atopic dermatitis (AD) is a chronic pruritic inflammatory disease that commonly presents in the pediatric population. Although definitions and diagnosis of AD have largely been agreed upon, allergists and dermatologists have similar and divergent approaches to the management of AD. This review facilitated integration of the American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma & Immunology Joint Task Force 2012 AD Practice Parameter and the 2014 American Academy of Dermatology guidelines to highlight the basic principles of AD management and discuss therapies and management of AD from the distinct perspectives of the allergist and dermatologist.

Le texte complet de cet article est disponible en PDF.

Key words : Atopic dermatitis, eczema, guidelines, Joint Task Force, American Academy of Dermatology, topical and systemic treatments

Abbreviations used : AAAAI, AAD, ACAAI, AD, JTF, MMF, TCI, TCS

Plan

Disclosure of potential conflict of interest: L. F. Eichenfield serves as a consultant for Allergan, Anacore/Pfizer, Galderman, Lilly, Otsuka/Medimetriks, TopMD, and Valeant; serves on the board for Valeant; and receives speakers' fees from Valeant. M. Boguniewicz receives personal fees from Omnia Education. The rest of the authors declare that they have no relevant conflicts of interest.

Export

Vol 139 - N° 4S

P. S49-S57 - avril 2017 Retour au numéro

Article précédent

Table of Contents

| Article suivant

Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?
Thomas Bieber, Angelo M. D'Erme, Cezmi A. Akdis, Claudia Traidl-Hoffmann, Roger Lauener, Georg Schäppi, Peter Schmid-Grendelmeier

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines - 19/04/17

Abstract

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL